Latest Systems biology Stories
Molecules in their breath, sweat and skin have been used to detect humans in a simulation of a collapsed building, raising the prospect of portable sensors for use in real-life situations, such as the devastating aftermath of the 9/11 attacks and more recent disasters in New Zealand and Japan.
Revealing how cells communicate, Tel Aviv University research could lead to new cancer drugs and more.
Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women.
In the wake of last year's creation of the first self-replicating cell with a synthetic genome â€“ which was quickly followed by a request from President Barack Obama for a report by the Presidential Commission for the Study of Bioethical Issues â€“ a series of essays in the Hastings Center Report examines the social challenges that synthetic biology presents.
Salk Institute and Dana Farber Cancer Institute researchers contribute to production of largest-ever map of plant protein interactions.
MAHWAH, N.J., July 25, 2011 /PRNewswire/ -- Heartland Bridge Capital (OTCBB:HLBC) announced that it has signed a term sheet to make an investment in HepatoChem Inc.
ATLANTA, July 25, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE Marked LC/MS/MS integrated solution for the quantification of everolimus (CerticanÂ®). (Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO ) Being displayed in Waters booth #3136 are these exciting new products. MassTrak(TM) Online Solid Phase Extraction Analyzer providing automated sample clean-up,...
Fluorescent Black, a wildly popular science fiction comic printed first as a periodical in Heavy Metal Magazine and later as a collected novel, will now be released in European territories, in three different languages: Spanish, French and English.
CARLSBAD, Calif., June 10, 2011 /PRNewswire/ -- Life Technologies Corporation has signed an exclusive license agreement for novel technology that enables synthetic biologists to effectively program and control the genetic circuitry in engineered pathways and organisms.
DENVER, June 6, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced it has entered into a non-exclusive co-marketing and reselling agreement with PREMIER Biosoft International (Palo Alto, CA) to advance lipidomics research.